Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Soros to Buy $40 Million of Sihuan Pharma’s Hong Kong IPO

publication date: Oct 14, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
According to press reports, George Soros, the billionaire international investor, has committed $40 million to Sihuan Pharma’s upcoming Hong Kong IPO, one of six cornerstone investors in the offering. Sihuan, China’s largest cardio-cerebral vascular drugmaker, plans to raise $749 million in its IPO. More details....

Stock Symbol: (HK: 0460)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners